Form 8-K - Current report:
SEC Accession No. 0000950170-25-087359
Filing Date
2025-06-17
Accepted
2025-06-17 16:10:26
Documents
11
Period of Report
2025-06-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K rapt-20250613.htm   iXBRL 8-K 44865
2 EX-3.1 rapt-ex3_1.htm EX-3.1 14069
  Complete submission text file 0000950170-25-087359.txt   166958

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapt-20250613.xsd EX-101.SCH 24830
13 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20250613_htm.xml XML 4716
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 251053414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)